[11C]phosgene: A versatile reagent for radioactive carbonyl insertion into medicinal radiotracers for positron emission tomography

Current Topics in Medicinal Chemistry

Volumn 10, Issue 16, 2010, Pages 1680-1700

  Roeda, Dirk ^a   Dollé, Frédéric ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

Carbon 11; Phosgene; Positron Emission Tomography; Radiochemistry

Indexed keywords

3,4 DIHYDROISOQUINOLINE 2 1H CARBONYL CHLORIDE C 11; AMMONIUM ISOCYANATE C 11; BARBITAL C 11; BENZAMIDE C 11; CARBAMIC ACID C 11; CARBAMOYL CHLORIDE C 11; CARBON 11; CARBON DIOXIDE C 11; CARBON MONOXIDE C 11; CARBONIC ACID DIETHYL ESTER C 11; CARBONIC ACID DIMETHYL ESTER C 11; CHLOROFORMIC ACID ETHYL ESTER C 11; DIMETHADIONE C 11; FLUOROURACIL C 11; GI 181771 C 11; ISOCYANATE C 11; ISOCYANIC ACID METHYL ESTER C 11; METHANE C 11; N,N' BIS(2 CHLOROETHYL)UREA C 11; N,N' DIPHENYLUREA C 11; NORMEPHENYTOIN C 11; PHENOBARBITAL C 11; PHENYTOIN C 11; PHOSGENE C 11; TEMOZOLOMIDE C 11; THYMIDINE C 11; THYMINE C 11; TRACER; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA C 11; CARBON; DIAGNOSTIC AGENT; PHOSGENE;

ARTICLE; CHEMICAL BOND; CYCLIZATION; CYCLOADDITION; DEHYDRATION; DRUG SYNTHESIS; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; CHEMISTRY; HUMAN; REVIEW;

CARBON RADIOISOTOPES; HUMANS; PHOSGENE; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS;

EID: 77958009659     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610793176710     Document Type: Article

References (107)

1. Babad, H.; Zeiler, A. G. Chemistry of phosgene. Chem. Rev., 1973, 73, 75-91.
2. Scott, P. J. H. Methods for the incorporation of carbon-11 to generate radiopharmaceuticals for PET imaging. Angew. Chem. Int. Ed., 2009, 48, 6001-6004.
3. 11Cphosgene without added carrier. Radiochem. Radioanal. Lett., 1978, 33, 175-178.
4. Roeda, D. Some Radiopharmaceuticals Derived from Carboneleven Labelled Phosgene: Synthesis and Clinical Application. Doctoral thesis, Vrije Universiteit, Amsterdam. INIS-MF-7674.
5. Huston, J. L.; Norris, T. H. Production of radioactive carbon monoxide and phosgene from barium carbonate. J. Am. Chem. Soc., 1948, 70, 1968-1969.
6. Calvin, M.; Heidelberger, C.; Reis, J. C.; Tolbert, B. M.; Yankich, P. E. Isotopic Carbon; Wiley: New York, 1949, p. 155.
7. 11COCl2. Int. J. Appl. Radiat. Isot., 1978, 29, 701-702.
8. Finn, R. D.; Christman, D. R.; Wolf, A. P. A Novel Synthesis of Carbon-11 Labelled Phosgene. Tenth International Hot Atom Chemistry Symposium. Loughborough University of Technology, England, September, 1979.
9. 11Chosgene and the preparation of some of its derivatives. Int. J. Appl. Radiat. Isot., 1981, 32, 931-932.
10. 11Chosgene. J. Labelled Comp. Radiopharm., 1981, 18, 11-12.
11. 11C]phosgene. Int. J. Nucl. Med. Biol., 1982, 9, 283-285.
12. Clark, J. C.; Buckingham P. D. Short-lived Radioactive Gases for Clinical Use; Butterworths: London, 1975, pp. 227-231.
13. 11C -labelled aromatic ketones. Appl. Radiat. Isot., 1997, 48, 1091-1095.
14. Iida, S. Effective reduction of C-11 carbon dioxide to C-11 carbon monoxide with magnesium metal. J. Labelled Comp. Radiopharm., 1989, 26, 155-156.
15. Sarkadi, É.; Elsinga, P. H.; Visser, T. J.; Luurtsema, G.; Vaalburg, W.; Kovács, Z. The search for the source of carrier carbon during [11C]COCl2 production. J. Labelled Comp. Radiopharm. 1997, 40, 736-737.
16. 11C-labeled phosene. J. Labelled Comp. Radiopharm., 1977, 13, 284.
17. 11C-labelled neuroleptic drug: Pimozide. Int. J. Appl. Radiat. Isot., 1980, 31, 545-548.
18. 11C]5,5-dimethyl-2,4-oxazolidinedione for studies with positron tomography. J. Nucl. Med., 1982, 23, 255-258.
19. 11Cabelled phosgene: An improved procedure and synthesis device. Int. J. Appl. Radiat. Isot., 1983, 34, 1558-1559.
20. 11C]5,5-dimethyl-2,4-oxazolidinedione with and without added dimethyl carbonate as a carrier for studies with positron tomography. Int. J. Appl. Radiat. Isot., 1985, 36, 793-802.
21. Manchot, M.; Lehmann, G. Über Entstehung von Phosgen bei der Einwirkung des Kohlen-oxydes auf Halogenide der Platinmetalle. Ber., 1930, 63, 1221-1224.
22. Manchot, M.; Enk, E. Über eine Verbindung des Einwertingen Ruthetiums. Ber., 1930, 63, 1635-1638.
23. Conway, T.; Diksic, M. Synthesis of no-carrier-added carbon-11 SarCNU: The sarcosinamide analog of the chemotherapeutic agent BCNU. J. Nucl. Med., 1988, 29, 1957-1960.
24. 11C)-HECNU: The hydroxyethyl analog of the chemotherapeutic agent BCNU. Appl. Raiat. Isot., 1991, 42, 441-446.
25. 11C. J. Labelled Comp. Radiopharm., 1986, 23, 1073.
26. Landais, P.; Crouzel, C. A new synthesis of carbon-11 labelled phosgene. Appl. Radiat. Isot., 1987, 38, 297-300.
27. 11C]CH4 using a niobium target chamber. Nucl. Med. Biol., 2004, 31, 825-827.
28. 11C]CH4 with I2. Nucl. Med. Biol., 1997, 24, 93-97.
29. 11C]methane. Appl. Radiat. Isot., 1997, 48, 153-157.
30. Dence, C. S.; Herrero, P.; Schwarz, S. W.; Mach, R. H.; Gropler, R. J.; Welch, M. J. Imaging myocardium enzymatic pathways with carbon-11 radiotracers. Methods Enzymol., 2004, 385, 286-315.
31. 11C]CGP-12177) as a preferred radioligand for -adrenergic receptors. Appl. Radiat. Isot., 1991, 42, 621-628.
32. 11COCl2. J. Labelled Comp. Radiopharm., 1997, 40, 306-308.
33. 11C]phosgene. Appl. Radiat. Isot., 1999, 51, 377-388.
34. 11C-Carbonyl]organo-isocyanates utilizing [11C]phosgene ([11C]organo-isocyanates from [11C]phosgene). Nucl. Med. Biol., 2001, 28, 991-998.
35. 11C]phosgene production with iron(III) oxide. J. Labelled Comp. Radiopharm., 2001, 44(Suppl 1), S1016-S1018.
36. 11C]phosgene with iron and iron (III) oxide. Nucl. Med. Biol., 2002, 29, 345-350.
37. 11C]CGP-12177, a radioligand for -adrenoreceptors. Nucl. Med. Comm., 2004, 25, 845-849.
38. 11C]phosgene using an environmental CCl4 gas detection tube. Nucl. Med. Biol., 2010, 37, 73-76.
39. 11C]phosgene synthesis. Tetrahedron Lett., 2010, 51, 313-316.
40. Crouzel, C.; Amano, R.; Fournier, D. Synthesis of carbon-11 labelled diazomethane. Appl. Radiat. Isot. 1987, 38, 669-670.
41. Diksic, M.; Farrokhzad, S.; Yamamoto, L.; Feindel, W. Synthesis of "no carrier added" 1,3-bis-(2-chloroethyl)nitrosourea (BCNU). J. Nucl. Med., 1982, 23, 895-898.
42. Dollé, F.; Martarello, L.; Bramoullé, Y.; Bottlaender, M.; Gee, A. D. Radiosynthesis of carbon-11-labelled GI181771, a new selective CCK-A agonist. J. Labelled Comp. Radiopharm., 2005, 48, 501-513.
43. 11C-labelled nitrosoureas. J. Radioanal. Nucl. Chem., 1985, 89, 45-54.
44. Brown, G.; Henderson, D.; Prenant, C.; Price, P.; Luthra, S. K.; Brady, F. A novel generic route to the synthesis of [C-11]isocyanates from [C-11]phosgene. J. Nucl. Med., 1998, 39(Suppl), 237P-238P.
45. 11C]Methylisocyanate: a new synthetic process. J. Labelled Compd., Radiopharm., 1994, 35, 103-104.
46. 11C]heptylphysostigmine. Appl. Radiat. Isot., 1995, 46, 167-170.
47. 11C-carbonyl] methylisocyanate. J. Labelled Comp. Radiopharm., 1997, 40, 371.
48. 11C-methyl]-8-carbamoyl-3methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies. J. Med. Chem., 2002, 45, 5448-5457.
49. 11C-urea for medical use. Int. J. Appl. Radiat. Isot., 1980, 31, 549-551.
50. Fosse, R.; De Graeve, P.; Thomas P-E. Synthèse de l'acide cyanique par l'action du phosgène sur l'ammoniac. C. R'Académie Sci., 1936, 202, 1544-1547.
51. 11C labelled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbiturates. Int. J. Appl. Radiat. Isot., 1981, 32, 843-845.
52. Calvin, M.; Heidelberger, C.; Reis, J. C.; Tolbert, B. M.; Yankwich, P. E. Isotopic Carbon; Wiley: New York, 1949, p 158.
53. Dollé, F.; Valette, H.; Hinnen, F.; Vaufrey, F.; Demphel, S.; Coulon, C.; Ottaviani, M.; Bottlaender, M.; Crouzel, C. Synthesis and preliminary evaluation of a carbon-11-labelled agonist of the 7 nicotinic acetylcholine receptor. J. Labelled Compd. Radiopharm., 2001, 44, 785-795.
54. Dollé, F.; Hinnen, F.; Valette, H.; Demphel, S.; Coulon, C.; Ottaviani, M.; Bottlaender, M.; Crouzel, C. Synthesis of a carbon-11 labelled agonist of the 7 nicotinic acetylcholine receptors. J. Labelled Comp. Radiopharm., 2001, 44(Suppl 1), S7-S8.
55. 11C]physostigmine. J. Labelled Comp. Radiopharm., 1993, 33, 277-284.
56. 11C]GI181771, a new selective CCK-A agonist. J. Labelled Comp. Radiopharm., 2005, 48(Suppl. 1), S141.
57. 11C]phosgene: A precursor for 2- [11C]thymidine. J. Labelled Comp. Radiopharm., 1993, 32, 178-179.
58. 11C]urea from [11C]cyanide. Int. J. Appl. Radiat. Isot., 1985, 36, 141-144.
59. Shorter, J. The conversion of ammonium cyanate into urea - A saga in reaction mechanisms. Chem. Soc. Rev. 1978, 1-14.
60. 11C-cyanide. Int. J. Appl. Radiat. Isot. 1983, 34, 1013-1014.
61. 11C]urea. Int. J. Appl. Radiat. Isot., 1985, 36, 739-740.
62. 11C]thymidine. J. Labelled Comp. Radiopharm., 1995, 37, 610-612.
63. 11C]AF-DX 384, a selective antagonist of M2 receptors for positron emission tomography studies. J. Labelled Comp. Radiopharm., 1994, 35, 425-426.
64. 11C]phosgene and tertiary amines. J. Labelled Comp. Radiopharm., 2001, 44(Suppl. 1), S128-S131.
65. Lemoucheux, L.; Rouden, J.; Ibazizene, M.; Sobrio, F.; Lasne, M.- C. Debenzylation of tertiary amines using phosgene or triphosgene: An efficient and rapid procedure for the preparation of carbamoyl chlorides and unsymmetrical ureas. Application in carbon-11 chemistry. J. Org. Chem., 2003, 68, 7289-7297.
66. Lemoucheux, L.; Rouden, J.; Lasne, M.-C. Synthesis of new ligands of cholinergic receptors. Strategies for their radiolabelling with positron emitters, carbon-11 or fluorine-18. J. Labelled Comp. Radiopharm., 2001, 44, 310-311.
67. 11C]phosgene: Rapid synthesis of a delta-lactam involving a new chemoselective lithiation-annulation method. J. Org. Chem., 2004, 69, 3787-3793.
68. 13N labelled BCNU and its in vivo pharmacokinetical study with PET. J. Labelled Comp. Radiopharm., 1982, 19, 1394.
69. Bestian, H. Process of preparing acylated halogen alkyl amines. US Pat. Appl., 2288178, July 3, 1939.
70. Bestian, H. Über einige Reaktionen des Äthylen-imins. Ann. Chem., 1950, 566, 210-244.
71. 11C]estramustine phosphate. Steroids, 1998, 63, 228-234.
72. 11C]estramustine. J. Labelled Comp. Radiopharm., 1997, 40, 788-789.
73. Matzner, M.; Kurkjy, R. P.; Cotter R. J. The chemistry of chloroformates. Chem. Rev., 1964, 645-687.
74. Ouellet, R.; Rousseau, J.; Brasseur, N.; van Lier, J. E.; Diksic, M.; Westera, G. Synthesis, receptor-binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol. J. Med. Chem., 1984, 27, 509-513.
75. Ali, H.; Rousseau, J.; Diksic, M.; van Lier, J. E. Synthesis, receptor-binding and target-tissue uptake of carbon-11-labeled carbamate derivatives of estradiol and hexestrol. Nucl. Med. Biol., 1992, 19, 175-182.
76. 11C]phosgene. J. Labelled Comp. Radiopharm., 2005, 48(Suppl 1), S181.
77. 11C]phosgene. Tetrahedron Lett., 2006, 47, 5321-5323.
78. 11C]5-fluorouracil for prognosis of cancer chemotherapy. J. Pharmacy Pharmaceut. Sci., 2007, 10, 212-216.
79. 11C]pyrimidines for positron emission tomography. Heterocycles, 2009, 77, 1307-1321.
80. 11C-labelled ketanserin: A selective serotonin S2 antagonist. J. Labelled Comp. Radiopharm., 1983, 20, 73-79.
81. 11C)-one (CGP 12177). J. Labelled Comp. Radiopharm., 1986, 23, 565-567.
82. 11C]-CGP 12177) from optically active precursors. J. Labelled Comp. Radiopharm., 1991, 29, 681-690.
83. Roger, G.; Lagnel, B.; Besret, L.; Bramoullé, Y.; Coulon, C.; Ottaviani, M.; Kassiou, M.; Bottlaender, M.; Valette, H.; Dollé, F. Synthesis, radiosynthesis and in vivo evaluation of 5-[3-(4benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2- [11C]one, as a potent NR1A/2B subtype selective NMDA PET radiotracer. Bioorg. Med. Chem. 2003, 11, 5401-5408.
84. Roger, G.; Lagnel, B.; Besret, L.; Bramoullé, Y.; Coulon, C.; Ottaviani, M.; Valette, H.; Kassiou, M.; Bottlaender, M.; Dollé, F. Synthesis and radiosynthesis of a novel NMDA ligand labelled with carbon-11. J. Labelled Comp. Radiopharm. 2003, 46(Suppl 1), S139.
85. 11C]RPR-72840A and its evaluation as a radioligand for the serotonin reuptake site in positron emission tomography. Bioorg. Med. Chem., 1997, 5, 397-403.
86. 11C-labeled uracil derivative for a PET tracer targeting thymidine phophorylase. Heterocycles 2008, 76, 237-241.
87. 11C]Lu 29-066, a 5-HT2 receptor antagonist. J. Labelled Comp. Radiopharm. 1999, 42, 437-446.
88. 11C-labelled DMO. Int. J. Appl. Radiat. Isot., 1984, 35, 1035-1037.
89. 11C]SL25.1188), a novel radioligand for imaging monoamine oxidase-B with PET. J. Labelled Comp. Radiopharm., 2008, 51, 153-158.
90. 11C]EMD-95885: A high affinity ligand for NR2B-containing NMDA receptors. J. Labelled Comp. Radiopharm., 2003, 46(Suppl. 1), S32.
91. Roger, G.; Dollé, F.; de Bruin, B.; Liu, X.; Besret, L.; Bramoullé, Y.; Coulon, C.; Ottaviani, M.; Bottlaender, M.; Valette, H.; Kassiou, M. Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: A high affinity ligand for NR2B-containing NMDA receptors. Bioorg. Med. Chem., 2004, 12, 3229-3237.
92. 11C]befloxatone, a selective radioligand for the in vivo imaging of MAO-A density using PET. J. Labelled Comp. Radiopharm., 2003, 46, 783-792.
93. Dollé, F.; Valette, H.; Bramoullé, Y.; Guenther, I.; Fuseau, C.; Coulon, C.; Lartizien, C.; Jegham, S.; George, P.; Curet, O.; Pinquier, J. L.; Bottlaender, M. Synthesis and in vivo imaging properties of [C-11]befloxatone: A novel highly potent positron emission tomography ligand for mono-amine oxidase-A. Bioorg. Med. Chem. Lett., 2003, 13, 1771-1775.
94. Bernard, S.; Fuseau, C.; Schmid, L.; Milcent, R.; Crouzel, C. PET studies in the baboon brain and biodistribution in the rat of new monoamine oxidase B inhibitors. J. Labelled Comp. Radiopharm., 1995, 37, 229-231.
95. 11C]-2(3H)-one. Eur. J. Nucl. Med., 1996, 23, 150-156.
96. Steel, C. J.; Luthra, S. K.; Brown, G. D.; Sergis, A. N.; Tochon-Danguy, H.; Tilsley, T. W. O.; Osman, S.; Waters, S. L.; Jones, T.; Price, P.; Labar, D.; Brady, F. An automated synthesis of 2- [11C]thymidine utilising [11C]phosgene. J. Labelled Comp. Radiopharm., 1994, 35, 324-326.
97. 11C]cyanide. Appl. Radiat. Isot., 1986, 37, 1033-1038.
98. 11C]thymidine for quantification of cellular proliferation with PET. Appl. Radiat. Isot., 1991, 42, 103-104.
99. 11C]uracil synthesis. Appl. Radiat. Isot., 1997, 48, 619-621.
100. 11C]5,5-dimethyloxazolidine-2,4-dione. Int. J. Appl. Radiat. Isot. 1982, 33, 647-651.
101. 11C]phenobarbital. Int. J. Appl. Radiat. Isot., 1983, 34, 1657-1658.
102. 11C]CO2 as a safe substitute for phosgene in the carbonylation of primary amines. J. Labelled Comp. Radiopharm., 1999, 42, 537-551.
103. 11C]ureas via triphenylphosphinimines. J. Labelled Comp. Radiopharm., 2006, 49, 321-330.
104. 11C]CO2 into carbamates. Angew. Chem. Int. Ed., 2009, 48, 3482-3485.
105. 11C-carbamoyl compounds. J. Org. Chem., 2002, 67, 3687-3692.
106. 11C-labelled N,N'-diphenylurea and ethyl phenylcarbamate by a rhodium-promoted carbonylation via [11C]isocyanatobenzene using phenyl azide and [11C]carbon monoxide. Org. Biomol. Chem., 2004, 2, 3063-3066.
107. Roeda, D.; Kuhnast, B.; Hammadi, A.; Dollé, F. The Service Hospitalier Frédéric Joliot - Contributions to PET chemistry over the years. J. Labelled Comp. Radiopharm., 2007, 50, 848-866.